Sun Pharmaceutical Industries Profit & Loss Annual

Trade

BSE: 524715 | NSE: SUNPHARMA | ISIN: INE044A01036 | Sector: Biotechnology & Drugs

1,804.65 +6.85 (0.38%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Revenue	48,496.85	43,885.68	38,654.49	33,498.14
Total Revenue	48,496.85	43,885.68	38,654.49	33,498.14
Costof Revenue Total	10,662.61	11,942.42	11,707.65	9,885.42
Gross Profit	37,834.24	31,943.26	26,946.84	23,612.72
Selling/ General/ Admin Expenses Total	9,429.06	19,394.87	15,945.42	14,344.76
Depreciation/ Amortization	2,556.64	2,529.43	2,143.74	2,079.95
Unusual Expense( Income)	494.32	188.37	4,570.27	4,307.00
Other Operating Expenses Total	15,418.18	738.24	709.74	734.39
Total Operating Expense	38,560.81	34,793.33	35,076.82	31,351.52
Operating Income	9,936.04	9,092.35	3,577.67	2,146.62
Interest Inc( Exp) Net- Non- Op Total	-2,023.40	2,812.30	5,347.30	5,862.80
Other Net	1,354.19	27.31	334.17	52.59
Net Income Before Taxes	11,087.89	9,408.43	4,481.32	2,799.37
Provisionfor Income Taxes	1,439.45	847.59	1,075.50	514.69
Net Income After Taxes	9,648.44	8,560.84	3,405.82	2,284.68
Minority Interest	-33.65	-39.36	-116.55	631.47
Equity In Affiliates	-384.10	-479.00	-165.40	-123.30
Net Income Before Extra Items	9,576.38	8,473.58	3,272.73	2,903.82
Net Income	9,576.38	8,473.58	3,272.73	2,903.82
Income Availableto Com Excl Extra Ord	9,576.38	8,473.58	3,272.73	2,903.82
Income Availableto Com Incl Extra Ord	9,576.38	8,473.58	3,272.73	2,903.82
Diluted Net Income	9,576.38	8,473.58	3,272.73	2,903.82
Diluted Weighted Average Shares	240.01	239.93	239.93	239.93
Diluted EPS Excluding Extra Ord Items	39.90	35.32	13.64	12.10
DPS- Common Stock Primary Issue	13.50	11.50	10.00	7.50
Diluted Normalized EPS	41.69	36.01	28.03	26.71
Gain( Loss)on Saleof Assets	-	75.40	347.50	138.80